Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (301-310 of 460) with videos related to

Pageof 46
Sort By:
Blood|April 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistenceJoseph S Durgin, Shin H Seo, Shadab Kazmi, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media DesignSaba Ghassemi, Francisco J Martinez-Becerra, Alyssa M Master, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
CD28 costimulation is essential for human T regulatory expansion and functionTatiana N Golovina, Tatiana Mikheeva, Megan M Suhoski, et al.
Blood|June 11, 2020
Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenomeQian Zhang, Elena J Orlando, Hong Y Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusionsDaniel H Sterman, Adri Recio, Andrew R Haas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Blood|May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantationGinna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Cell|August 10, 2019
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint BlockadeJoseph L Benci, Lexus R Johnson, Ruth Choa, et al.
Pageof 46

Showing results (301-310 of 460) with videos related to

Sort By:
Pageof 46
Blood|April 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistenceJoseph S Durgin, Shin H Seo, Shadab Kazmi, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media DesignSaba Ghassemi, Francisco J Martinez-Becerra, Alyssa M Master, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
CD28 costimulation is essential for human T regulatory expansion and functionTatiana N Golovina, Tatiana Mikheeva, Megan M Suhoski, et al.
Blood|June 11, 2020
Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenomeQian Zhang, Elena J Orlando, Hong Y Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2010
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusionsDaniel H Sterman, Adri Recio, Andrew R Haas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Blood|May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantationGinna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
Cell|August 10, 2019
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint BlockadeJoseph L Benci, Lexus R Johnson, Ruth Choa, et al.
Pageof 46